Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2017

01-04-2017

The Obesity Epidemic in the Veterans Health Administration: Prevalence Among Key Populations of Women and Men Veterans

Authors: Jessica Y. Breland, PhD, Ciaran S. Phibbs, PhD, Katherine J. Hoggatt, PhD, Donna L. Washington, MD, MPH, Jimmy Lee, MS, Sally Haskell, MD, Uchenna S. Uchendu, MD, Fay S. Saechao, MPH, Laurie C. Zephyrin, MD, Susan M. Frayne, MD, MPH

Published in: Journal of General Internal Medicine | Special Issue 1/2017

Login to get access

Abstract

Background

Most US adults are overweight or obese. Understanding differences in obesity prevalence across subpopulations could facilitate the development and dissemination of weight management services.

Objectives

To inform Veterans Health Administration (VHA) weight management initiatives, we describe obesity prevalence among subpopulations of VHA patients.

Design

Cross-sectional descriptive analyses of fiscal year 2014 (FY2014) national VHA administrative and clinical data, stratified by gender. Differences ≥5% higher than the population mean were considered clinically significant.

Participants

Veteran VHA primary care patients with a valid weight within ±365 days of their first FY2014 primary care visit, and a valid height (98% of primary care patients).

Main Measures

We used VHA vital signs data to ascertain height and weight and calculate body mass index, and VHA outpatient, inpatient, and fee basis data to identify sociodemographic- and comorbidity-based subpopulations.

Key Results

Among nearly five million primary care patients (347,112 women, 4,567,096 men), obesity prevalence was 41% (women 44%, men 41%), and overweight prevalence was 37% (women 31%, men 38%). Across the VHA’s 140 facilities, obesity prevalence ranged from 28% to 49%. Among gender-stratified subpopulations, obesity prevalence was high among veterans under age 65 (age 18-44: women 40%, men 46%; age 45-64: women 49%, men 48%). Obesity prevalence varied across racial/ethnic and comorbidity subpopulations, with high obesity prevalence among black women (51%), women with schizophrenia (56%), and women and men with diabetes (68%, 56%).

Conclusions

Overweight and obesity are common among veterans served by the VHA. VHA’s weight management initiatives have the potential to avert long-term morbidity arising from obesity-related conditions. High-risk groups—such as black women veterans, women veterans with schizophrenia, younger veterans, and Native Hawaiian/Other Pacific Islander and American Indian/Alaska Native veterans—may require particular attention to ensure that systems improvement efforts at the population level do not inadvertently increase health disparities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in Obesity Among Adults in the United States, 2005 to 2014. J Am Med Assoc. 2016;315(21):2284–91.CrossRef Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in Obesity Among Adults in the United States, 2005 to 2014. J Am Med Assoc. 2016;315(21):2284–91.CrossRef
2.
go back to reference Expert Panel Members, Jensen M, Ryan D, Donato K et al. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl 2):S5–39. Expert Panel Members, Jensen M, Ryan D, Donato K et al. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl 2):S5–39.
3.
go back to reference Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. J Am Med Assoc. 2013;309(1):71–82.CrossRef Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. J Am Med Assoc. 2013;309(1):71–82.CrossRef
4.
go back to reference The Management of Overweight and Obesity Working Group. VA/DOD Clinical practice guidelines for screening and management of overweight and obesity. Version 2.0. Washington, DC: Department of Veteran Affairs, Department of Defense., 2014. The Management of Overweight and Obesity Working Group. VA/DOD Clinical practice guidelines for screening and management of overweight and obesity. Version 2.0. Washington, DC: Department of Veteran Affairs, Department of Defense., 2014.
6.
go back to reference Noel PH, Copeland LA, Perrin RA, et al. VHA Corporate Data Warehouse height and weight data: opportunities and challenges for health services research. J Rehabil Res Dev. 2010;47(8):739–50.CrossRefPubMed Noel PH, Copeland LA, Perrin RA, et al. VHA Corporate Data Warehouse height and weight data: opportunities and challenges for health services research. J Rehabil Res Dev. 2010;47(8):739–50.CrossRefPubMed
9.
go back to reference Washington DL, Bean-Mayberry B, Hamilton AB, Cordasco KM, Yano EM. Women veterans’ healthcare delivery preferences and use by military service era: findings from the National Survey of Women Veterans. J Gen Intern Med. 2013;28(Suppl 2):S571–6.CrossRefPubMed Washington DL, Bean-Mayberry B, Hamilton AB, Cordasco KM, Yano EM. Women veterans’ healthcare delivery preferences and use by military service era: findings from the National Survey of Women Veterans. J Gen Intern Med. 2013;28(Suppl 2):S571–6.CrossRefPubMed
11.
go back to reference Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015(219):1–8. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015(219):1–8.
12.
13.
go back to reference Smith TJ, Marriott BP, Dotson L, et al. Overweight and obesity in military personnel: sociodemographic predictors. Obesity (Silver Spring). 2012;20(7):1534–8.CrossRef Smith TJ, Marriott BP, Dotson L, et al. Overweight and obesity in military personnel: sociodemographic predictors. Obesity (Silver Spring). 2012;20(7):1534–8.CrossRef
15.
go back to reference Frayne SM, Parker VA, Christiansen CL, et al. Health status among 28,000 women veterans: The VA Women’s Health Program Evaluation Project. J Gen Intern Med. 2006;21(Suppl 3):S40–6. Frayne SM, Parker VA, Christiansen CL, et al. Health status among 28,000 women veterans: The VA Women’s Health Program Evaluation Project. J Gen Intern Med. 2006;21(Suppl 3):S40–6.
16.
go back to reference Luncheon C, Zack M. Health-related quality of life among US veterans and civilians by race and ethnicity. Prev Chronic Dis. 2012;9:E108.PubMedPubMedCentral Luncheon C, Zack M. Health-related quality of life among US veterans and civilians by race and ethnicity. Prev Chronic Dis. 2012;9:E108.PubMedPubMedCentral
17.
go back to reference Wilson NJ, Kizer KW. The VA health care system: an unrecognized national safety net. Health Aff (Millwood). 1997;16(4):200–4.CrossRef Wilson NJ, Kizer KW. The VA health care system: an unrecognized national safety net. Health Aff (Millwood). 1997;16(4):200–4.CrossRef
18.
go back to reference Yu W, Ravelo A, Wagner TH, et al. Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev. 2003;60(3 Suppl):146s–67s.CrossRefPubMed Yu W, Ravelo A, Wagner TH, et al. Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev. 2003;60(3 Suppl):146s–67s.CrossRefPubMed
19.
go back to reference Dursa EK, Barth SK, Bossarte RM, Schneiderman AI. Demographic, Military, and Health Characteristics of VA Health Care Users and Nonusers Who Served in or During Operation Enduring Freedom or Operation Iraqi Freedom, 2009–2011. Public Health Reports. 2016:0033354916676279. Dursa EK, Barth SK, Bossarte RM, Schneiderman AI. Demographic, Military, and Health Characteristics of VA Health Care Users and Nonusers Who Served in or During Operation Enduring Freedom or Operation Iraqi Freedom, 2009–2011. Public Health Reports. 2016:0033354916676279.
20.
go back to reference Nelson KM, Starkebaum GA, Reiber GE. Veterans using and uninsured veterans not using Veterans Affairs (VA) health care. Public Health Rep. 2007;122(1):93–100. Nelson KM, Starkebaum GA, Reiber GE. Veterans using and uninsured veterans not using Veterans Affairs (VA) health care. Public Health Rep. 2007;122(1):93–100.
21.
go back to reference Littman AJ, Damschroder LJ, Verchinina L, et al. National evaluation of obesity screening and treatment among veterans with and without mental health disorders. Gen Hosp Psychiatry. 2015;37(1):7–13.CrossRefPubMed Littman AJ, Damschroder LJ, Verchinina L, et al. National evaluation of obesity screening and treatment among veterans with and without mental health disorders. Gen Hosp Psychiatry. 2015;37(1):7–13.CrossRefPubMed
22.
go back to reference Funderburk JS, Arigo D, Kenneson A. Initial engagement and attrition in a national weight management program: demographic and health predictors. Transl Behav Med. 2016;6(3): 358-68. Funderburk JS, Arigo D, Kenneson A. Initial engagement and attrition in a national weight management program: demographic and health predictors. Transl Behav Med. 2016;6(3): 358-68.
23.
go back to reference McVay MA, Yancy WS Jr, Vijan S, et al. Obesity-related health status changes and weight-loss treatment utilization. Am J Prev Med. 2014;46(5):465–72.CrossRefPubMed McVay MA, Yancy WS Jr, Vijan S, et al. Obesity-related health status changes and weight-loss treatment utilization. Am J Prev Med. 2014;46(5):465–72.CrossRefPubMed
24.
go back to reference Littman AJ, Boyko EJ, McDonell MB, Fihn SD. Evaluation of a weight management program for veterans. Prev Chronic Dis. 2012;9:E99.PubMedPubMedCentral Littman AJ, Boyko EJ, McDonell MB, Fihn SD. Evaluation of a weight management program for veterans. Prev Chronic Dis. 2012;9:E99.PubMedPubMedCentral
25.
go back to reference Kahwati LC, Lance TX, Jones KR, Kinsinger LS. RE-AIM evaluation of the Veterans Health Administration’s MOVE! Weight Management Program. Transl Behav Med. 2011;1(4):551–60.CrossRefPubMedPubMedCentral Kahwati LC, Lance TX, Jones KR, Kinsinger LS. RE-AIM evaluation of the Veterans Health Administration’s MOVE! Weight Management Program. Transl Behav Med. 2011;1(4):551–60.CrossRefPubMedPubMedCentral
26.
go back to reference Fialkowski MK, Okoror TA, Boushey CJ. The relevancy of community-based methods: using diet within Native American and Alaska Native adult populations as an example. Clin Transl Sci. 2012;5(3):295–300.CrossRefPubMedPubMedCentral Fialkowski MK, Okoror TA, Boushey CJ. The relevancy of community-based methods: using diet within Native American and Alaska Native adult populations as an example. Clin Transl Sci. 2012;5(3):295–300.CrossRefPubMedPubMedCentral
28.
go back to reference Jackson SL, Long Q, Rhee MK, et al. Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational study. Lancet Diabetes Endocrinol. 2015;3(3):173–80.CrossRefPubMedPubMedCentral Jackson SL, Long Q, Rhee MK, et al. Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational study. Lancet Diabetes Endocrinol. 2015;3(3):173–80.CrossRefPubMedPubMedCentral
29.
go back to reference Green CA, Yarborough BJH, Leo MC, et al. The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. Am J Psychiatry. 2015;172(1):71–81. Green CA, Yarborough BJH, Leo MC, et al. The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. Am J Psychiatry. 2015;172(1):71–81.
30.
go back to reference Goldberg RW, Reeves G, Tapscott S, et al. "MOVE!" Outcomes of a weight loss program modified for veterans with serious mental illness. Psychiatr Serv. 2013;64(8):737–44.CrossRefPubMedPubMedCentral Goldberg RW, Reeves G, Tapscott S, et al. "MOVE!" Outcomes of a weight loss program modified for veterans with serious mental illness. Psychiatr Serv. 2013;64(8):737–44.CrossRefPubMedPubMedCentral
31.
go back to reference Kumanyika SK, Whitt-Glover MC, Haire-Joshu D. What works for obesity prevention and treatment in black Americans? Research directions. Obes Rev. 2014;15(Suppl 4):204–12.CrossRefPubMed Kumanyika SK, Whitt-Glover MC, Haire-Joshu D. What works for obesity prevention and treatment in black Americans? Research directions. Obes Rev. 2014;15(Suppl 4):204–12.CrossRefPubMed
32.
go back to reference Pagoto SL, Schneider KL, Oleski JL, Luciani JM, Bodenlos JS, Whited MC. Male inclusion in randomized controlled trials of lifestyle weight loss interventions. Obesity (Silver Spring). 2012;20(6):1234–9.CrossRef Pagoto SL, Schneider KL, Oleski JL, Luciani JM, Bodenlos JS, Whited MC. Male inclusion in randomized controlled trials of lifestyle weight loss interventions. Obesity (Silver Spring). 2012;20(6):1234–9.CrossRef
33.
go back to reference Robertson C, Avenell A, Boachie C, et al. Should weight loss and maintenance programmes be designed differently for men? A systematic review of long-term randomised controlled trials presenting data for men and women: The ROMEO project. Obes Res Clin Pract. 2016;101(1): 70-84. Robertson C, Avenell A, Boachie C, et al. Should weight loss and maintenance programmes be designed differently for men? A systematic review of long-term randomised controlled trials presenting data for men and women: The ROMEO project. Obes Res Clin Pract. 2016;101(1): 70-84.
34.
go back to reference Young MD, Morgan PJ, Plotnikoff RC, Callister R, Collins CE. Effectiveness of male-only weight loss and weight loss maintenance interventions: a systematic review with meta-analysis. Obes Rev. 2012;13(5):393–408.CrossRefPubMed Young MD, Morgan PJ, Plotnikoff RC, Callister R, Collins CE. Effectiveness of male-only weight loss and weight loss maintenance interventions: a systematic review with meta-analysis. Obes Rev. 2012;13(5):393–408.CrossRefPubMed
35.
go back to reference Jackson JW, Williams DR, VanderWeele TJ. Disparities at the intersection of marginalized groups. Soc Psychiatry Psychiatr Epidemiol. 2016;51(10):1349–59.CrossRefPubMed Jackson JW, Williams DR, VanderWeele TJ. Disparities at the intersection of marginalized groups. Soc Psychiatry Psychiatr Epidemiol. 2016;51(10):1349–59.CrossRefPubMed
36.
go back to reference Cooper SJ, Reynolds GP, Barnes T, et al. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. J Psychopharmacol. 2016;30(8):717-48. Cooper SJ, Reynolds GP, Barnes T, et al. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. J Psychopharmacol. 2016;30(8):717-48.
37.
go back to reference Maguen S, Madden E, Cohen B, et al. The relationship between body mass index and mental health among Iraq and Afghanistan veterans. J Gen Intern Med. 2013;28(Suppl 2):S563–70.CrossRefPubMed Maguen S, Madden E, Cohen B, et al. The relationship between body mass index and mental health among Iraq and Afghanistan veterans. J Gen Intern Med. 2013;28(Suppl 2):S563–70.CrossRefPubMed
38.
go back to reference Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220–9.CrossRefPubMed Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220–9.CrossRefPubMed
39.
go back to reference Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease—a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137.CrossRefPubMedPubMedCentral Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease—a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137.CrossRefPubMedPubMedCentral
40.
go back to reference Zulman DM, Yoon J, Cohen DM, Wagner TH, Ritchie C, Asch SM. Multimorbidity and health care utilization among high-cost patients: Implications for care coordination. J Gen Intern Med. 2013;28(1):S123. Zulman DM, Yoon J, Cohen DM, Wagner TH, Ritchie C, Asch SM. Multimorbidity and health care utilization among high-cost patients: Implications for care coordination. J Gen Intern Med. 2013;28(1):S123.
41.
go back to reference Roberson LL, Aneni EC, Maziak W, et al. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality—a systematic review. BMC Public Health. 2014;14(1):1–12.CrossRef Roberson LL, Aneni EC, Maziak W, et al. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality—a systematic review. BMC Public Health. 2014;14(1):1–12.CrossRef
42.
go back to reference Boffetta P, McLerran D, Chen Y, et al. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One. 2011;6(6):e19930.CrossRefPubMedPubMedCentral Boffetta P, McLerran D, Chen Y, et al. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One. 2011;6(6):e19930.CrossRefPubMedPubMedCentral
43.
go back to reference Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond). 2008;32(Suppl 3):S56–9.CrossRef Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond). 2008;32(Suppl 3):S56–9.CrossRef
44.
go back to reference Sorkin JD, Muller DC, Andres R. Longitudinal change in height of men and women: implications for interpretation of the body mass index: the Baltimore Longitudinal Study of Aging. Am J Epidemiol. 1999;150(9):969–77.CrossRefPubMed Sorkin JD, Muller DC, Andres R. Longitudinal change in height of men and women: implications for interpretation of the body mass index: the Baltimore Longitudinal Study of Aging. Am J Epidemiol. 1999;150(9):969–77.CrossRefPubMed
46.
go back to reference Myers CA, Slack T, Martin CK, Broyles ST, Heymsfield SB. Regional disparities in obesity prevalence in the United States: A spatial regime analysis. Obesity (Silver Spring). 2015;23(2):481–7.CrossRef Myers CA, Slack T, Martin CK, Broyles ST, Heymsfield SB. Regional disparities in obesity prevalence in the United States: A spatial regime analysis. Obesity (Silver Spring). 2015;23(2):481–7.CrossRef
47.
go back to reference Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008;27(3):759–69.CrossRef Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008;27(3):759–69.CrossRef
48.
go back to reference Eggleston EM, Finkelstein JA. Finding the role of health care in population health. JAMA. 2014;311(8):797–8.CrossRefPubMed Eggleston EM, Finkelstein JA. Finding the role of health care in population health. JAMA. 2014;311(8):797–8.CrossRefPubMed
Metadata
Title
The Obesity Epidemic in the Veterans Health Administration: Prevalence Among Key Populations of Women and Men Veterans
Authors
Jessica Y. Breland, PhD
Ciaran S. Phibbs, PhD
Katherine J. Hoggatt, PhD
Donna L. Washington, MD, MPH
Jimmy Lee, MS
Sally Haskell, MD
Uchenna S. Uchendu, MD
Fay S. Saechao, MPH
Laurie C. Zephyrin, MD
Susan M. Frayne, MD, MPH
Publication date
01-04-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue Special Issue 1/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3962-1

Other articles of this Special Issue 1/2017

Journal of General Internal Medicine 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine